EN IT

updated 14.10.2019

SCCA-LISA Literature

24. Turato C, Scarpa M, Kotsafti A, Cappon A, Quarta S, Biasiolo A, Cavallin F, Trevellin E, Guzzardo V, Fassan M, Chiarion-Sileni V, Castoro C, Rugge M, Vettor R, Scarpa M, Pontisso P. Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.. Cancer Sci.. 110(5):1552-1563. 2019. doi: 10.1111/cas.13986
23. Gringeri E, Di Giunta M, Biasiolo A, Ruvoletto M, Villano G, Zarantonello L, Pontisso P, Cillo U. Serum and bile squamous cell carcinoma antigen detection: a new prognostic marker in patients with perihilar cholangiocarcinoma. Dig Liver Dis. 50(S1):40. 2018. doi: 10.1016/j.dld.2018.01.116
22. Raggi C, Cappon A, Correnti M, Andersen JB, Forti E, Cavalloni G, Torchio E, Pontisso P, Marra F. The protease-inhibitor SerpinB3 outlines a stem-like subset in human cholangiocarcinoma. Dig Liver Dis. 50(S1):47. 2018. doi: 10.1016/j.dld.2018.01.049
21. Gringeri E, Di Giunta M, Biasiolo A, D'Amico FE, Fasolo E, Pontisso P, Cillo U. Serum and bile squamous cell carcinoma antigen 1 (SCCA1) detection: a new diagnostic approach in patients with perihilar cholangiocarcinoma (pCCA). The Liver Meeting-American Association for the Study of Liver Diseases (AASLD). Washington DC, USA. 2017. doi: 10.1002/hep.29501
20. Turato C, Buendia MA, Fabre M, Redon MJ, Branchereau S, Quarta S, Ruvoletto M, Perilongo G, Grotzer MA, Gatta A, Pontisso P. Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?. Eur J Cancer. 48(8):1219-26. 2012. doi: 10.1016/j.ejca.2011.06.004
19. Turato C, Biasiolo A, Pengo P, Frecer V, Quarta S, Fasolato S, Ruvoletto M, Beneduce L, Zuin J, Fassina G, Gatta A, Pontisso P. Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD. Exp Biol Med. 236:281-90. 2011.
18. Turato C, Buendia MA, Fabre M, Redon MJ, Branchereau S, Quarta S, Ruvoletto MG, Perilongo G, Grotzer MA, Gatta A, Pontisso P. Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumor?. Dig Liver Dis. 43(S2):S66. 2011. doi: 10.1016/S1590-8658(11)60005-4
17. Quarta S, Vidalino L, Turato C, Ruvoletto MG, Calabrese F, Valente M, Cannito S, Fassina G, Parola M, Gatta A, Pontisso P. SERPINB3 induces epithelial-mesenchymal transition. J Pathol. 221(3):343-56. 2010. doi: 10.1002/path.2708
16. Cannito S, Turato C, Quarta S, Colombatto S, Biasiolo A, Pontisso P, Parola M. Hypoxia up-regulates SERPINB3 in HEPG2 cells: a redox sensitive event related to epithelial to mesenchymal transition and invasiveness. Dig Liver Dis. 41(3):A31-A32. 2009. doi: 10.1016/j.dld.2008.12.066
15. Cannito S, Turato C, Quarta S, Paternostro C, Colombatto S, Biasiolo A, Pontisso P, Parola M. Serpin B3 up-regulation by hypoxia in HepG2 cells: A redox sensitive, Ras/ERK and PI3-K mediated event related to invasiveness and epithelial to mesenchymal transition. Dig Liver Dis. 41(3):A19. 2009. doi: 10.1016/j.dld.2009.02.046
14. Lunardi F, Pontisso P, Rea F, Villano G, Gnoato M, Agostini C, Valente M, Calabrese F. Serpin B3 transgenic mice are more susceptible to lung fibrosis and epithelial proliferation. Virchows Arch. 455(S1):S84. 2009. doi: 10.1007/s00428-009-0805-z
13. Trerotoli P, Fransvea E, Angelotti U, Antonaci G, Lupo L, Mazzocca A, Mangia A, Antonaci S, Giannelli G. Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC. Mol Cancer. 8:29. 2009. doi: 10.1186/1476-4598-8-29
12. Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, Trerotoli P, Giannelli G, Manas D, Reeves H. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer. 8:200. 2008. doi: 10.1186/1471-2407-8-200
11. Hussein MM, Ibrahim AA, Abdella HM, Montasser IF, Hassan MI. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Indian J Cancer. 45(4):167-72. 2008. doi: 10.4103/0019-509X.44666
10. Cavalletto L, Caberlotto C, Calabrese F, Pontisso P, Bernardinello E, Biasiolo A, Giacometti C, Gottardo A, Gatta A, Chemello L. Clinical significance of serum and liver tissue SCCA in chronic hepatitis C. Dig Liver Dis. 39(3):A18. 2007. doi: 10.1016/j.dld.2006.12.067
9. Giannelli G, Antonaci S. Hepatocellular carcinoma: tumoral or peritumoral disease?. Recenti Prog Med. 98(1):23-8. 2007.
8. Giannelli G, Fransvea E, Trerotoli P, Beaugrand M, Marinosci F, Lupo L, Nkontchou G, Dentico P, Antonaci S. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta. 383(1-2):147-52. 2007. doi: 10.1016/j.cca.2007.05.014
7. Wright LM, Kreikemeier JT, Fimmel CJ. A concise review of serum markers for hepatocellular cancer. Cancer Detect Prev. 31(1):35-44. 2007.
6. Giannelli G, Antonaci S. New frontiers in biomarkers for hepatocellular carcinoma. Dig Liver Dis. 38(11):854-9. 2006. doi: 10.1016/j.dld.2006.05.007
5. Beneduce L, Castaldi F, Marino M, Pontisso P, Fassina G. Comparison of free and IgM-complexed squamous cell carcinoma antigen in hepatocellular carcinoma. J Hepatol. 42:89. 2005.
4. Giannelli G, Marinosci F, Sgarra C, Lupo L, Dentico P, Antonaci S. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer. 116(4):579-83. 2005. doi: 10.1002/ijc.20847
3. Giannelli G, Marinosci F, Trerotoli P, Volpe A, Quaranta M, Dentico P, Antonaci S. SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC. Int J Cancer. 117(3):506-9. 2005. doi: 10.1002/ijc.21189
2. Pontisso P, Calabrese F, Benvegnù L, Belluco C, Ruvoletto M, Marino M, Beneduce L, Valente M, Nitti D, Alberti A, Gatta A, Fassina G. Squamous cell carcinoma antigen variants overexpression in hepatocellular carcinoma. Proceedings 11th International Symposium on Viral Hepatitis & Liver Disease. 445-6. 2004.
1. Pontisso P, Calabrese F, Benvegnù L, Lise M, Belluco C, Ruvoletto MG, Marino M, Valente M, Nitti D, Gatta A, Fassina G. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer. 90:833-7. 2004. doi: 10.1038/sj.bjc.6601543